123 related articles for article (PubMed ID: 16847953)
21. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
[TBL] [Abstract][Full Text] [Related]
22. Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme.
Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
HIV Med; 2007 Mar; 8(2):80-5. PubMed ID: 17352763
[TBL] [Abstract][Full Text] [Related]
23. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.
Riddler SA; Li X; Chu H; Kingsley LA; Dobs A; Evans R; Palella F; Visscher B; Chmiel JS; Sharrett A
HIV Med; 2007 Jul; 8(5):280-7. PubMed ID: 17561873
[TBL] [Abstract][Full Text] [Related]
25. [Diabetic ketoacidosis in an HIV-infected patient undergoing antiretroviral therapy].
Holm MR; Hansen BR; Røder ME
Ugeskr Laeger; 2006 Feb; 168(9):920-1. PubMed ID: 16513058
[TBL] [Abstract][Full Text] [Related]
26. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
Mildvan D; Creagh T; Leitz G;
Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
[TBL] [Abstract][Full Text] [Related]
28. Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network.
Chaix ML; Desquilbet L; Descamps D; Costagliola D; Deveau C; Galimand J; Goujard C; Signori-Schmuck A; Schneider V; Tamalet C; Pellegrin I; Wirden M; Masquelier B; Brun-Vezinet F; Rouzioux C; Meyer L; ;
Antivir Ther; 2007; 12(8):1305-10. PubMed ID: 18240870
[TBL] [Abstract][Full Text] [Related]
29. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study.
Dray-Spira R; Spire B; Heard I; Lert F;
AIDS; 2007 Jan; 21 Suppl 1():S5-12. PubMed ID: 17159588
[TBL] [Abstract][Full Text] [Related]
31. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
Herida M; Mary-Krause M; Kaphan R; Cadranel J; Poizot-Martin I; Rabaud C; Plaisance N; Tissot-Dupont H; Boue F; Lang JM; Costagliola D
J Clin Oncol; 2003 Sep; 21(18):3447-53. PubMed ID: 12972519
[TBL] [Abstract][Full Text] [Related]
32. The inability to take medications openly at home: does it help explain gender disparities in HAART use?
Sayles JN; Wong MD; Cunningham WE
J Womens Health (Larchmt); 2006 Mar; 15(2):173-81. PubMed ID: 16536681
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for and outcome of hyperlactatemia in HIV-infected persons: is there a need for routine lactate monitoring?
Imhof A; Ledergerber B; Günthard HF; Haupts S; Weber R;
Clin Infect Dis; 2005 Sep; 41(5):721-8. PubMed ID: 16080096
[TBL] [Abstract][Full Text] [Related]
34. Effect of highly active antiretroviral therapy on multiple AIDS-defining illnesses among male HIV seroconverters.
Cain LE; Cole SR; Chmiel JS; Margolick JB; Rinaldo CR; Detels R
Am J Epidemiol; 2006 Feb; 163(4):310-5. PubMed ID: 16371516
[TBL] [Abstract][Full Text] [Related]
35. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
Leonard EG; McComsey GA
Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
[TBL] [Abstract][Full Text] [Related]
36. Antiretroviral combination therapy in HIV-1 infected women and men: are their responses different?
Zorrilla CD
Int J Fertil Womens Med; 2000; 45(2):195-9. PubMed ID: 10831190
[TBL] [Abstract][Full Text] [Related]
37. Gender differences in quality of HIV care in Ryan White CARE Act-funded clinics.
Hirschhorn LR; McInnes K; Landon BE; Wilson IB; Ding L; Marsden PV; Malitz F; Cleary PD
Womens Health Issues; 2006; 16(3):104-12. PubMed ID: 16765286
[TBL] [Abstract][Full Text] [Related]
38. Lactic acidosis in HIV-I infected patients receiving antiretroviral therapy.
Patel AK; Patel K; Patel J
J Assoc Physicians India; 2004 Aug; 52():666-9. PubMed ID: 15847366
[TBL] [Abstract][Full Text] [Related]
39. Anthropometrics and examiner-reported body habitus abnormalities in the multicenter AIDS cohort study.
Palella FJ; Cole SR; Chmiel JS; Riddler SA; Visscher B; Dobs A; Williams C
Clin Infect Dis; 2004 Mar; 38(6):903-7. PubMed ID: 14999638
[TBL] [Abstract][Full Text] [Related]
40. Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study.
Thorsteinsson K; Ladelund S; Jensen-Fangel S; Johansen IS; Katzenstein TL; Pedersen G; Storgaard M; Obel N; Lebech AM
BMC Infect Dis; 2012 Nov; 12():293. PubMed ID: 23140254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
